Quick Answer
AbbVie Inc. reported Operating Income of $15.07 billion for fiscal year 2025.
AbbVie Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $15.07B | +65.0% |
| 2024 | $9.14B | -28.4% |
| 2023 | $12.76B | -29.6% |
| 2022 | $18.12B | +1.1% |
| 2021 | $17.92B | +57.7% |
| 2020 | $11.36B | -12.5% |
| 2019 | $12.98B | +103.4% |
| 2018 | $6.38B | -33.1% |
| 2017 | $9.54B | +2.2% |
| 2016 | $9.34B | +23.9% |
| 2015 | $7.54B | +121.0% |
| 2014 | $3.41B | -39.8% |
| 2013 | $5.66B | -2.6% |
| 2012 | $5.82B | +60.7% |
| 2011 | $3.62B | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.90B | -50.3% | -61.1% |
| June 30, 2025 | $4.89B | +22.4% | +31.1% |
| March 31, 2025 | $3.73B | +33.4% | -2.6% |
| September 30, 2024 | $3.83B | +68.0% | -4.2% |
| June 30, 2024 | $4.00B | -11.4% | +42.9% |
| March 31, 2024 | $2.80B | +1.1% | +22.7% |
| September 30, 2023 | $2.28B | -50.4% | -49.5% |
| June 30, 2023 | $4.51B | +37.0% | +63.0% |
- AbbVie Inc. showed an increase of +65.0% in Operating Income compared to the prior fiscal year.
- Over the 2011–2025 period, AbbVie Inc.’s operating income has grown by 316.4% (from $3.62 billion to $15.07 billion).
- The most recent figure is from AbbVie Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: